MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 49 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,229 | -5.1% | 1,727,570 | -2.9% | 0.00% | +33.3% |
| Q2 2023 | $2,348 | +262.9% | 1,778,772 | +94.2% | 0.00% | +200.0% |
| Q1 2023 | $647 | -31.4% | 915,909 | -27.2% | 0.00% | 0.0% |
| Q4 2022 | $943 | -99.9% | 1,257,369 | +1.9% | 0.00% | -50.0% |
| Q3 2022 | $1,062,000 | +55.7% | 1,233,614 | +102.6% | 0.00% | +100.0% |
| Q2 2022 | $682,000 | +114.5% | 608,909 | +114.6% | 0.00% | – |
| Q1 2022 | $318,000 | -9.9% | 283,800 | +28.6% | 0.00% | – |
| Q4 2021 | $353,000 | -63.4% | 220,600 | -44.7% | 0.00% | -100.0% |
| Q3 2021 | $965,000 | +6.7% | 398,900 | +39.9% | 0.00% | 0.0% |
| Q2 2021 | $904,000 | +0.4% | 285,100 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $900,000 | -30.0% | 267,200 | -25.6% | 0.00% | 0.0% |
| Q4 2020 | $1,286,000 | +2196.4% | 359,200 | +1594.3% | 0.00% | – |
| Q3 2020 | $56,000 | -63.6% | 21,200 | -57.9% | 0.00% | – |
| Q2 2020 | $154,000 | -62.8% | 50,400 | -60.1% | 0.00% | – |
| Q4 2019 | $414,000 | -16.4% | 126,323 | -24.0% | 0.00% | – |
| Q3 2019 | $495,000 | +0.2% | 166,123 | -15.2% | 0.00% | – |
| Q2 2019 | $494,000 | – | 195,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |